USD 26.2
(-7.62%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 8.56 Billion USD | -3.31% |
2022 | 8.85 Billion USD | 264.38% |
2021 | 2.43 Billion USD | 29.89% |
2020 | 1.87 Billion USD | 105.43% |
2019 | 910.86 Million USD | 12.96% |
2018 | 806.37 Million USD | -13.78% |
2017 | 935.25 Million USD | 140.89% |
2016 | 388.25 Million USD | -4.49% |
2015 | 406.5 Million USD | -9.98% |
2014 | 451.55 Million USD | 66.4% |
2013 | 271.36 Million USD | 12.3% |
2012 | 241.64 Million USD | -13.35% |
2011 | 278.89 Million USD | 29.96% |
2010 | 214.59 Million USD | 27.96% |
2009 | 167.69 Million USD | 17.43% |
2008 | 142.8 Million USD | 6.7% |
2007 | 133.83 Million USD | 5.34% |
2006 | 127.04 Million USD | 11.59% |
2005 | 113.84 Million USD | 1.03% |
2004 | 112.69 Million USD | -4.03% |
2003 | 117.42 Million USD | 42.17% |
2002 | 82.59 Million USD | 0.24% |
2001 | 82.39 Million USD | 0.44% |
2000 | 82.03 Million USD | 0.0% |
1998 | 52.6 Million USD | 10.04% |
1997 | 47.8 Million USD | 13.0% |
1996 | 42.3 Million USD | 27.03% |
1995 | 33.3 Million USD | -3.48% |
1994 | 34.5 Million USD | 4.86% |
1993 | 32.9 Million USD | 55.19% |
1992 | 21.2 Million USD | 10.99% |
1991 | 19.1 Million USD | -15.49% |
1990 | 22.6 Million USD | 276.67% |
1989 | 6 Million USD | 3.45% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 6.68 Billion USD | -0.21% |
2024 Q1 | 6.7 Billion USD | -21.72% |
2023 Q4 | 8.56 Billion USD | 0.28% |
2023 Q2 | 8.55 Billion USD | -2.69% |
2023 Q1 | 8.78 Billion USD | -0.78% |
2023 FY | 8.56 Billion USD | -3.31% |
2023 Q3 | 8.53 Billion USD | -0.13% |
2022 Q4 | 8.85 Billion USD | 2.31% |
2022 FY | 8.85 Billion USD | 264.38% |
2022 Q2 | 8.82 Billion USD | 185.23% |
2022 Q1 | 3.09 Billion USD | 27.27% |
2022 Q3 | 8.65 Billion USD | -1.89% |
2021 FY | 2.43 Billion USD | 29.89% |
2021 Q4 | 2.43 Billion USD | 15.38% |
2021 Q1 | 2.09 Billion USD | 12.09% |
2021 Q2 | 1.8 Billion USD | -13.81% |
2021 Q3 | 2.1 Billion USD | 16.53% |
2020 Q2 | 972.93 Million USD | 0.64% |
2020 Q4 | 1.87 Billion USD | 49.77% |
2020 FY | 1.87 Billion USD | 105.43% |
2020 Q1 | 966.76 Million USD | 6.14% |
2020 Q3 | 1.24 Billion USD | 28.41% |
2019 Q3 | 867.51 Million USD | 2.52% |
2019 FY | 910.86 Million USD | 12.96% |
2019 Q2 | 846.18 Million USD | -6.59% |
2019 Q1 | 905.85 Million USD | 12.34% |
2019 Q4 | 910.86 Million USD | 5.0% |
2018 FY | 806.37 Million USD | -13.78% |
2018 Q1 | 865.64 Million USD | -7.44% |
2018 Q2 | 763.5 Million USD | -11.8% |
2018 Q3 | 793.88 Million USD | 3.98% |
2018 Q4 | 806.37 Million USD | 1.57% |
2017 FY | 935.25 Million USD | 140.89% |
2017 Q4 | 935.25 Million USD | 126.0% |
2017 Q1 | 404.49 Million USD | 4.18% |
2017 Q2 | 398.53 Million USD | -1.47% |
2017 Q3 | 413.82 Million USD | 3.84% |
2016 Q1 | 378.75 Million USD | -6.83% |
2016 FY | 388.25 Million USD | -4.49% |
2016 Q4 | 388.25 Million USD | 3.12% |
2016 Q3 | 376.49 Million USD | 1.84% |
2016 Q2 | 369.69 Million USD | -2.39% |
2015 FY | 406.5 Million USD | -9.98% |
2015 Q4 | 406.5 Million USD | -2.99% |
2015 Q2 | 429.21 Million USD | -5.71% |
2015 Q1 | 455.19 Million USD | 0.81% |
2015 Q3 | 419.04 Million USD | -2.37% |
2014 Q1 | 271.41 Million USD | 0.02% |
2014 Q2 | 258.51 Million USD | -4.75% |
2014 FY | 451.55 Million USD | 66.4% |
2014 Q3 | 267.73 Million USD | 3.57% |
2014 Q4 | 451.55 Million USD | 68.65% |
2013 Q1 | 257.07 Million USD | 6.38% |
2013 FY | 271.36 Million USD | 12.3% |
2013 Q4 | 271.36 Million USD | 0.8% |
2013 Q3 | 269.2 Million USD | 1.55% |
2013 Q2 | 265.1 Million USD | 3.12% |
2012 FY | 241.64 Million USD | -13.35% |
2012 Q4 | 241.64 Million USD | 2.06% |
2012 Q1 | 238.03 Million USD | -14.65% |
2012 Q2 | 232.51 Million USD | -2.32% |
2012 Q3 | 236.77 Million USD | 1.83% |
2011 Q1 | 263.32 Million USD | 22.71% |
2011 Q4 | 278.89 Million USD | 2.05% |
2011 FY | 278.89 Million USD | 29.96% |
2011 Q3 | 273.28 Million USD | 7.48% |
2011 Q2 | 254.25 Million USD | -3.44% |
2010 Q3 | 213.46 Million USD | -3.45% |
2010 Q4 | 214.59 Million USD | 0.53% |
2010 FY | 214.59 Million USD | 27.96% |
2010 Q1 | 233.41 Million USD | 40.32% |
2010 Q2 | 221.09 Million USD | -5.28% |
2009 FY | 167.69 Million USD | 17.43% |
2009 Q1 | 125.24 Million USD | -12.3% |
2009 Q2 | 118.81 Million USD | -5.13% |
2009 Q3 | 149.79 Million USD | 26.08% |
2009 Q4 | 166.34 Million USD | 11.05% |
2008 Q4 | 142.8 Million USD | -4.09% |
2008 FY | 142.8 Million USD | 6.7% |
2008 Q2 | 132.63 Million USD | -1.17% |
2008 Q3 | 148.89 Million USD | 12.26% |
2008 Q1 | 134.2 Million USD | 0.27% |
2007 Q2 | 113.88 Million USD | -3.51% |
2007 FY | 133.83 Million USD | 5.34% |
2007 Q4 | 133.83 Million USD | 11.67% |
2007 Q3 | 119.85 Million USD | 5.24% |
2007 Q1 | 118.02 Million USD | -7.1% |
2006 FY | 127.04 Million USD | 11.59% |
2006 Q1 | 115.83 Million USD | 1.74% |
2006 Q3 | 107.51 Million USD | -0.62% |
2006 Q4 | 127.04 Million USD | 18.17% |
2006 Q2 | 108.18 Million USD | -6.6% |
2005 Q1 | 110.25 Million USD | -2.16% |
2005 FY | 113.84 Million USD | 1.03% |
2005 Q4 | 113.84 Million USD | 15.58% |
2005 Q3 | 98.49 Million USD | 9.15% |
2005 Q2 | 90.24 Million USD | -18.15% |
2004 Q4 | 112.69 Million USD | 0.95% |
2004 Q3 | 111.62 Million USD | -2.41% |
2004 Q2 | 114.38 Million USD | -2.91% |
2004 Q1 | 117.81 Million USD | 0.33% |
2004 FY | 112.69 Million USD | -4.03% |
2003 Q3 | 86.86 Million USD | 4.46% |
2003 Q4 | 117.42 Million USD | 35.18% |
2003 FY | 117.42 Million USD | 42.17% |
2003 Q1 | 85.1 Million USD | 3.04% |
2003 Q2 | 83.16 Million USD | -2.28% |
2002 FY | 82.59 Million USD | 0.24% |
2002 Q4 | 82.59 Million USD | 4.46% |
2002 Q3 | 79.06 Million USD | -1.36% |
2002 Q2 | 80.15 Million USD | 0.87% |
2002 Q1 | 79.47 Million USD | -3.55% |
2001 Q4 | 82.39 Million USD | 3.13% |
2001 FY | 82.39 Million USD | 0.44% |
2001 Q2 | 77.02 Million USD | -4.16% |
2001 Q3 | 79.89 Million USD | 3.73% |
2001 Q1 | 80.37 Million USD | -2.02% |
2000 FY | 82.03 Million USD | 0.0% |
2000 Q1 | 70.44 Million USD | 0.0% |
2000 Q4 | 82.03 Million USD | 30.75% |
2000 Q2 | 69.85 Million USD | -0.82% |
2000 Q3 | 62.74 Million USD | -10.19% |
1999 Q3 | 59.2 Million USD | 15.18% |
1999 Q2 | 51.4 Million USD | -2.28% |
1999 Q1 | 52.6 Million USD | 14.1% |
1998 Q3 | 46.3 Million USD | -0.64% |
1998 Q4 | 46.1 Million USD | -0.43% |
1998 FY | 52.6 Million USD | 10.04% |
1998 Q1 | 47.8 Million USD | 5.05% |
1998 Q2 | 46.6 Million USD | -2.51% |
1997 Q1 | 42.3 Million USD | 18.49% |
1997 Q2 | 41.6 Million USD | -1.65% |
1997 FY | 47.8 Million USD | 13.0% |
1997 Q4 | 45.5 Million USD | 7.82% |
1997 Q3 | 42.2 Million USD | 1.44% |
1996 Q1 | 33.3 Million USD | -0.6% |
1996 FY | 42.3 Million USD | 27.03% |
1996 Q2 | 33.3 Million USD | 0.0% |
1996 Q3 | 33.2 Million USD | -0.3% |
1996 Q4 | 35.7 Million USD | 7.53% |
1995 Q4 | 33.5 Million USD | 4.36% |
1995 Q2 | 32.8 Million USD | -4.93% |
1995 Q3 | 32.1 Million USD | -2.13% |
1995 FY | 33.3 Million USD | -3.48% |
1995 Q1 | 34.5 Million USD | 10.93% |
1994 Q2 | 30.5 Million USD | -7.29% |
1994 Q4 | 31.1 Million USD | 0.97% |
1994 Q1 | 32.9 Million USD | 28.52% |
1994 Q3 | 30.8 Million USD | 0.98% |
1994 FY | 34.5 Million USD | 4.86% |
1993 Q3 | 25.3 Million USD | 17.67% |
1993 Q2 | 21.5 Million USD | 1.42% |
1993 Q1 | 21.2 Million USD | 7.61% |
1993 FY | 32.9 Million USD | 55.19% |
1993 Q4 | 25.6 Million USD | 1.19% |
1992 Q3 | 19.4 Million USD | 4.86% |
1992 FY | 21.2 Million USD | 10.99% |
1992 Q1 | 19.1 Million USD | 3.8% |
1992 Q2 | 18.5 Million USD | -3.14% |
1992 Q4 | 19.7 Million USD | 1.55% |
1991 Q1 | 22.6 Million USD | 0.0% |
1991 Q3 | 18.5 Million USD | -6.57% |
1991 Q2 | 19.8 Million USD | -12.39% |
1991 Q4 | 18.4 Million USD | -0.54% |
1991 FY | 19.1 Million USD | -15.49% |
1990 Q1 | 6 Million USD | 0.0% |
1990 FY | 22.6 Million USD | 276.67% |
1989 FY | 6 Million USD | 3.45% |
1989 Q1 | 5.8 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Akoya Biosciences, Inc. | 180.36 Million USD | -4647.545% |
AngioDynamics, Inc. | 317.67 Million USD | -2595.588% |
AtriCure, Inc. | 613.93 Million USD | -1294.796% |
Avinger, Inc. | 13.77 Million USD | -62086.638% |
Azenta, Inc. | 2.88 Billion USD | -196.741% |
BioLife Solutions, Inc. | 412.71 Million USD | -1974.827% |
The Cooper Companies, Inc. | 11.65 Billion USD | 26.553% |
Daxor Corporation | 34.86 Million USD | -24457.817% |
Ekso Bionics Holdings, Inc. | 28.91 Million USD | -29511.661% |
Femasys Inc. | 27.75 Million USD | -30751.542% |
GlucoTrack, Inc. | 4.9 Million USD | -174479.001% |
Harvard Bioscience, Inc. | 137.36 Million USD | -6133.784% |
Hologic, Inc. | 9.15 Billion USD | 6.476% |
ICU Medical, Inc. | 4.37 Billion USD | -95.574% |
Intuitive Surgical, Inc. | 15.44 Billion USD | 44.545% |
KORU Medical Systems, Inc. | 28.46 Million USD | -29987.166% |
LeMaitre Vascular, Inc. | 346.77 Million USD | -2369.332% |
Innovative Eyewear, Inc. | 6.21 Million USD | -137597.825% |
Innovative Eyewear, Inc. | 6.21 Million USD | -137597.825% |
Masimo Corporation | 3.04 Billion USD | -181.542% |
Microbot Medical Inc. | 8.32 Million USD | -102735.355% |
Meihua International Medical Technologies Co., Ltd. | 171.91 Million USD | -4881.0% |
Merit Medical Systems, Inc. | 2.32 Billion USD | -268.267% |
Nephros, Inc. | 11.86 Million USD | -72095.43% |
NovoCure Limited | 1.14 Billion USD | -647.132% |
NEXGEL, Inc. | 9.95 Million USD | -85918.081% |
NEXGEL, Inc. | 9.95 Million USD | -85918.081% |
Singular Genomics Systems, Inc. | 265.46 Million USD | -3125.674% |
OraSure Technologies, Inc. | 482.84 Million USD | -1673.468% |
Pro-Dex, Inc. | 54.21 Million USD | -15696.163% |
Pulse Biosciences, Inc. | 60.8 Million USD | -13983.12% |
Predictive Oncology Inc. | 14.41 Million USD | -59294.826% |
Precision Optics Corporation, Inc. | 16.91 Million USD | -50531.56% |
Repligen Corporation | 2.82 Billion USD | -203.182% |
Sanara MedTech Inc. | 73.87 Million USD | -11491.941% |
STAAR Surgical Company | 488.69 Million USD | -1652.249% |
Sharps Technology, Inc. | 11.78 Million USD | -72534.705% |
Utah Medical Products, Inc. | 135.45 Million USD | -6221.59% |
DENTSPLY SIRONA Inc. | 7.37 Billion USD | -16.189% |
Jin Medical International Ltd. | 32.9 Million USD | -25924.931% |